Stock AMP AMPLIFON S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Amplifon S.p.A.

Equities

AMP

IT0004056880

Medical Equipment, Supplies & Distribution

Market Closed - Borsa Italiana
Other stock markets
 11:44:59 2024-05-31 am EDT 		5-day change 1st Jan Change
33.85 EUR -0.09% Intraday chart for Amplifon S.p.A. -0.06% +8.01%
May. 22 Futures cautious; UK inflation at 2.3 percent in April AN
May. 21 Mib falls to 34,600 area; Saipem and Unipol bullish AN

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 5,712 7,643 10,667 6,249 7,068 7,656 - -
Enterprise Value (EV) 1 6,498 8,277 11,539 7,581 8,399 8,744 8,605 8,506
P/E ratio 52.4 x 75.5 x 67.6 x 34.9 x 45.2 x 39.3 x 31.5 x 26.6 x
Yield - 0.65% 0.55% 1.04% 0.93% 0.98% 1.14% 1.38%
Capitalization / Revenue 3.3 x 4.91 x 5.48 x 2.95 x 3.13 x 3.11 x 2.85 x 2.62 x
EV / Revenue 3.75 x 5.32 x 5.92 x 3.58 x 3.72 x 3.55 x 3.2 x 2.91 x
EV / EBITDA 17.5 x 22.3 x 23.9 x 14.4 x 15.5 x 14.3 x 12.7 x 11.4 x
EV / FCF 43.4 x 32.2 x 45.3 x 30.7 x 30.4 x 37 x 30.4 x 27.5 x
FCF Yield 2.31% 3.1% 2.21% 3.25% 3.29% 2.7% 3.29% 3.64%
Price to Book 8.23 x 9.55 x 11.5 x 6.02 x 6.43 x 6.2 x 5.43 x 4.88 x
Nbr of stocks (in thousands) 222,760 224,527 224,815 224,622 225,517 226,162 - -
Reference price 2 25.64 34.04 47.45 27.82 31.34 33.85 33.85 33.85
Announcement Date 3/4/20 3/3/21 3/3/22 3/1/23 3/7/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,732 1,556 1,948 2,119 2,260 2,463 2,686 2,918
EBITDA 1 370.6 371 482.8 525.3 541.6 609.5 677.7 746.2
EBIT 1 201.3 168.5 262.1 285.3 274 320.9 377.9 426.7
Operating Margin 11.62% 10.83% 13.45% 13.46% 12.12% 13.03% 14.07% 14.62%
Earnings before Tax (EBT) 1 150.1 139.3 223.4 243.7 209.7 263.9 321.7 373.9
Net income 1 108.7 101 157.8 178.5 155.1 199.9 242.5 275.5
Net margin 6.28% 6.49% 8.1% 8.42% 6.86% 8.12% 9.03% 9.44%
EPS 2 0.4890 0.4510 0.7020 0.7960 0.6930 0.8609 1.075 1.273
Free Cash Flow 1 149.9 256.9 254.9 246.7 276.3 236 283.1 309.7
FCF margin 8.65% 16.52% 13.08% 11.64% 12.23% 9.58% 10.54% 10.61%
FCF Conversion (EBITDA) 40.44% 69.25% 52.8% 46.96% 51.02% 38.73% 41.77% 41.51%
FCF Conversion (Net income) 137.88% 254.36% 161.54% 138.21% 178.14% 118.07% 116.74% 112.41%
Dividend per Share 2 - 0.2200 0.2600 0.2900 0.2900 0.3314 0.3858 0.4676
Announcement Date 3/4/20 3/3/21 3/3/22 3/1/23 3/7/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 S1 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 613.9 - 568.2 495.8 541.4 1,037 502.5 579.4 540.3 573.5 1,114 531.3 615 573.1 635.8 588.1 686.1
EBITDA 1 131.3 - 156.6 112.9 147.3 260.1 108.8 155.8 123.5 152.5 276 109.8 155.8 136.8 174.1 128 178.6
EBIT 1 31.5 - 95.3 55.2 87 142.2 48.4 94 61.5 86.04 147.5 - 81.1 65.7 103.7 57.67 108.9
Operating Margin 5.13% - 16.77% 11.13% 16.07% 13.71% 9.63% 16.22% 11.38% 15% 13.24% - 13.19% 11.46% 16.32% 9.81% 15.88%
Earnings before Tax (EBT) 17.8 - 84.5 43.7 76.2 119.9 40.1 83.7 41.6 70.88 112.5 40.13 67 50.2 - - -
Net income 12.6 77.1 57 30.6 55.6 86.5 29.2 63 29.3 52.06 81.36 29.2 51.7 34.9 - - -
Net margin 2.05% - 10.03% 6.17% 10.27% 8.34% 5.81% 10.87% 5.42% 9.08% 7.3% 5.5% 8.41% 6.09% - - -
EPS - - 0.2540 0.1360 - - 0.1300 0.2810 - - - - - - - - -
Dividend per Share - - - - - - - - - - - - - - - - -
Announcement Date 7/29/20 7/29/21 3/3/22 5/3/22 7/28/22 7/28/22 10/26/22 3/1/23 5/2/23 7/27/23 7/27/23 10/30/23 3/7/24 5/6/24 - - -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 787 634 871 1,332 1,331 1,088 950 850
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.123 x 1.708 x 1.804 x 2.535 x 2.457 x 1.785 x 1.401 x 1.139 x
Free Cash Flow 1 150 257 255 247 276 236 283 310
ROE (net income / shareholders' equity) 16.8% 13.5% 18.3% 18.2% 14.5% 19.8% 20% 20.5%
ROA (Net income/ Total Assets) - 3.32% - 5.03% 4.27% 5.96% 6.59% -
Assets 1 - 3,040 - 3,545 3,634 3,353 3,681 -
Book Value Per Share 2 3.120 3.560 4.110 4.620 4.880 5.460 6.230 6.940
Cash Flow per Share 2 1.440 1.730 2.050 2.050 1.850 1.970 2.160 2.260
Capex 1 91.1 57.2 111 106 140 151 141 164
Capex / Sales 5.26% 3.68% 5.7% 5.02% 6.19% 6.13% 5.25% 5.63%
Announcement Date 3/4/20 3/3/21 3/3/22 3/1/23 3/7/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Amplifon S.p.A.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
33.85 EUR
Average target price
35.91 EUR
Spread / Average Target
+6.10%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
AMPLIFON S.P.A. Stock Amplifon S.p.A.
+8.01% 8.3B
ABBOTT LABORATORIES Stock Abbott Laboratories
-7.16% 178B
MEDTRONIC PLC Stock Medtronic plc
-1.23% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.86% 67.04B
DEXCOM, INC. Stock DexCom, Inc.
-4.28% 47.23B
CENCORA, INC. Stock Cencora, Inc.
+10.32% 44.62B
HOYA CORPORATION Stock Hoya Corporation
+8.14% 42.5B
TERUMO CORPORATION Stock Terumo Corporation
+15.53% 25.22B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-5.88% 24.14B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-5.38% 23.69B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. AMP Stock
  4. Financials Amplifon S.p.A.